WEP CLINICAL PARTNERS WITH MYLAN TO PROVIDE PRODUCT FOR HIGHLY DRUG-RESISTANT TUBERCULOSIS

WEP Clinical (WEP), the specialist pharmaceutical services company, has partnered with Mylan N.V. (Mylan), a global pharmaceutical company, to launch a Named Patient Access Program (NPAP) for a new chemical entity used to treat [...]